You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-19. New and all clients entering outpatient and inpatient treatment: distribution (percentage) by primary drug at treatment in 2005 for those countries supplying data [see all tables in this series...]

Part (iv) All clients entering inpatient treatment

Country		Opioids	Cocaine	Stimulants	Hypnotics/sedatives	Hallucinogens	Volatile substances	Cannabis	Other substances	Base (known status)	Status unknown	Total
Bulgaria		96.3	0.5	1.0	0.5	0.0	0.2	1.5	0.0	588	0	588
Czech Republic		31.5	0.3	51.4	1.7	0.3	2.4	11.7	0.7	1757	0	1757
Denmark		53.2	5.2	6.9	2.7	0.0	0.0	22.4	9.6	406	84	490
Germany		44.8	6.8	3.4	4.6	0.1	0.1	13.4	26.8	5682	992	6674
Ireland		51.4	19.0	2.9	2.0	0.2	0.0	24.4	0.1	802	0	802
Greece	(1)	94.1	1.8	0.5	1.0	0.0	0.0	2.5	0.2	1637	0	1637
Cyprus		89.7	6.7	0.0	0.6	0.0	0.0	3.0	0.0	165	0	165
Luxembourg		72.8	21.3	3.7	0.0	0.0	0.0	2.2	0.0	136	0	136
Hungary		12.6	0.8	9.3	54.6	1.0	2.2	12.4	7.1	5246	7	5253
Romania		48.3	0.3	1.0	19.4	0.0	1.3	2.3	27.4	1529	9	1538
Slovakia		30.4	0.7	25.7	9.1	0.4	10.0	22.2	1.4	769	0	769
Finland		46.4	0.1	27.1	11.1	0.2	0.5	14.2	0.4	1155	0	1155
Sweden		35.6	1.2	38.7	10.3	0.0	0.3	12.1	1.7	2637	0	2637
United Kingdom	(2)	80.2	11.2	2.3	2.0	0.1	0.2	3.4	0.8	2762	183	2945
Turkey		50.3	3.7	5.5	3.2	0.0	13.4	22.4	1.5	2050	28	2078
Total		45.5	4.0	12.4	15.0	0.3	2.0	11.7	9.1	27321	1303	28624

Notes:

Only countries supplying data are reported.

(1) In case of Greece 'Speedball' is included under the category 'other substance'.

(2) Data from UK refer to collection period between 01.04.2004 and 31.03.2005.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - TDI - inpatient treatment centres.